AlphaCentric Advisors’s Spyre Therapeutics SYRE Stock Holding History

AlphaCentric Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$335K	Buy
2021 Q4	–	Sell
2021 Q3	$875K	Buy
2021 Q2	$644K	Buy
2021 Q1	$166K	Buy
2020 Q4	$31K	Buy
2020 Q3	$21K	Buy